X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-09-11 | CTTH | Ctt Pharmaceutical Holdings, Inc. | CEO | P - Purchase | $0.06 | +750 | 5,795,500 | 0% | +$41 | ||||||
2024-09-11 | CTTH | Ctt Pharmaceutical Holdings, Inc. | CEO | P - Purchase | $0.06 | +1,100 | 5,044,750 | 0% | +$61 | ||||||
2024-08-03 | CTTH | Ctt Pharmaceutical Holdings, Inc. | CEO | P - Purchase | $0.06 | +1,000 | 5,043,650 | 0% | +$60 | ||||||
2024-08-27 | CTTH | Ctt Pharmaceutical Holdings, Inc. | CEO | P - Purchase | $0.06 | +550 | 5,042,650 | 0% | +$33 | ||||||
2024-08-19 | CTTH | Ctt Pharmaceutical Holdings, Inc. | CEO | P - Purchase | $0.05 | +2,900 | 5,042,100 | 0% | +$145 | ||||||
2024-08-12 | CTTH | Ctt Pharmaceutical Holdings, Inc. | CEO | P - Purchase | $0.04 | +1,300 | 5,039,200 | 0% | +$52 | ||||||
2024-08-06 | CTTH | Ctt Pharmaceutical Holdings, Inc. | CEO | P - Purchase | $0.04 | +2,200 | 5,037,900 | 0% | +$92 | ||||||
2024-08-05 | CTTH | Ctt Pharmaceutical Holdings, Inc. | CEO | P - Purchase | $0.04 | +1,000 | 5,035,700 | 0% | +$42 | ||||||
2024-08-01 | CTTH | Ctt Pharmaceutical Holdings, Inc. | CEO | P - Purchase | $0.04 | +1,600 | 5,034,700 | 0% | +$64 | ||||||
2024-07-26 | CTTH | Ctt Pharmaceutical Holdings, Inc. | CEO | P - Purchase | $0.04 | +3,100 | 5,033,100 | 0% | +$124 | ||||||
2024-07-24 | CTTH | Ctt Pharmaceutical Holdings, Inc. | CEO | P - Purchase | $0.04 | +1,700 | 5,030,000 | 0% | +$68 | ||||||
2024-07-18 | CTTH | Ctt Pharmaceutical Holdings, Inc. | CEO | P - Purchase | $0.05 | +2,000 | 5,028,300 | 0% | +$100 | ||||||
2024-07-16 | CTTH | Ctt Pharmaceutical Holdings, Inc. | CEO | P - Purchase | $0.06 | +1,800 | 5,026,300 | 0% | +$108 | ||||||
2024-07-11 | CTTH | Ctt Pharmaceutical Holdings, Inc. | CEO | P - Purchase | $0.06 | +1,070 | 5,024,500 | 0% | +$64 | ||||||
2024-07-11 | CTTH | Ctt Pharmaceutical Holdings, Inc. | CEO | P - Purchase | $0.06 | +2,730 | 5,023,430 | 0% | +$164 | ||||||
2024-07-05 | CTTH | Ctt Pharmaceutical Holdings, Inc. | CEO | P - Purchase | $0.06 | +1,454 | 5,020,700 | 0% | +$87 | ||||||
2024-06-25 | CTTH | Ctt Pharmaceutical Holdings, Inc. | CEO | P - Purchase | $0.06 | +1,300 | 5,019,246 | 0% | +$78 | ||||||
2024-06-20 | CTTH | Ctt Pharmaceutical Holdings, Inc. | CEO | P - Purchase | $0.07 | +1,000 | 5,017,946 | 0% | +$70 | ||||||
2024-06-11 | CTTH | Ctt Pharmaceutical Holdings, Inc. | CEO | P - Purchase | $0.05 | +1,990 | 4,929,990 | 0% | +$99 | ||||||
2024-06-03 | CTTH | Ctt Pharmaceutical Holdings, Inc. | CEO | P - Purchase | $0.02 | +7,376 | 4,158,000 | 0% | +$148 | ||||||
2024-05-21 | CTTH | Ctt Pharmaceutical Holdings, Inc. | CEO | P - Purchase | $0.03 | +3,236 | 4,150,624 | 0% | +$84 | ||||||
2024-05-07 | CTTH | Ctt Pharmaceutical Holdings, Inc. | CEO | P - Purchase | $0.04 | +9,500 | 4,167,388 | 0% | +$380 | ||||||
2024-05-02 | CTTH | Ctt Pharmaceutical Holdings, Inc. | CEO | P - Purchase | $0.03 | +4,388 | 4,157,888 | 0% | +$136 | ||||||
2022-02-18 | CTTH | Ctt Pharmaceutical Holdings, Inc. | CEO | P - Purchase | $0.02 | +500,000 | 2,383,500 | +27% | +$10,000 | ||||||
2022-08-18 | CTTH | Ctt Pharmaceutical Holdings, Inc. | CEO | P - Purchase | $0.02 | +500,000 | 1,883,500 | +36% | +$10,000 | ||||||
2023-03-27 | CTTH | Ctt Pharmaceutical Holdings, Inc. | CEO | P - Purchase | $0.02 | +8,700 | 883,500 | +1% | +$191 | ||||||
2023-03-03 | CTTH | Ctt Pharmaceutical Holdings, Inc. | CEO | P - Purchase | $0.04 | +3,840 | 874,800 | 0% | +$134 | ||||||
2023-02-08 | CTTH | Ctt Pharmaceutical Holdings, Inc. | CEO | P - Purchase | $0.04 | +4,960 | 870,960 | +1% | +$174 | ||||||
2023-01-30 | CTTH | Ctt Pharmaceutical Holdings, Inc. | CEO | P - Purchase | $0.03 | +9,000 | 866,000 | +1% | +$225 | ||||||
2023-01-25 | CTTH | Ctt Pharmaceutical Holdings, Inc. | CEO | P - Purchase | $0.02 | +61,695 | 857,000 | +8% | +$1,481 |
A | Amended filing |
D | Derivative transaction in filing (usually option exercise) |
E | Error detected in filing |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |